Zhong Ji Longevity Science Group Limited (HK:0767)
:0767
Want to see HK:0767 full AI Analyst Report?
0767 Stock Chart & Stats
HK$0.51
-HK$0.01(-5.85%)
At close: 4:00 PM EST
HK$0.51
-HK$0.01(-5.85%)
Day’s Range― - ―
52-Week RangeHK$0.32 - HK$0.72
Previous CloseN/A
Volume650.00K
Average Volume (3M)487.89K
Market Cap
HK$267.39M
Enterprise ValueHK$223.20M
Total Cash (Recent Filing)HK$24.30M
Total Debt (Recent Filing)HK$5.57M
Price to Earnings (P/E)―
Beta-0.07
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding636,654,300
10 Day Avg. Volume325,210
30 Day Avg. Volume487,892
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)0.75
Price to Sales (P/S)1.80
P/FCF Ratio-12.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative LeverageVery low debt levels materially reduce refinancing and solvency risk, giving the company durable financial flexibility. With limited leverage the firm can prioritize operational fixes or targeted investments over urgent external financing, supporting resilience over the next several months.
Sizeable Equity BufferA stable, sizeable equity base provides an enduring capital cushion to absorb continued losses while management pursues recovery actions. This preserves solvency and optionality for restructuring, asset reinvestment or slower, measured growth without immediate capital raises.
Historical Cash GenerationPrior-year positive operating and free cash flow demonstrates the business can generate cash under the right operational conditions. That historical cash-generation ability supports a plausible path to sustainable cash flow if revenues stabilize or costs are restructured.
Bears Say
Sustained Losses & Margin ErosionLarge negative net margins over consecutive years indicate structural profitability problems. Persistent losses erode retained capital, reduce reinvestment capacity, and undermine long-term return on equity, making durable margin recovery necessary to restore shareholder value and reinstate internal funding.
Negative Operating And Free Cash FlowConsecutive years of negative operating and free cash flow create dependency on existing liquidity or external funding. This weak cash conversion constrains working capital, limits strategic investments, and raises refinancing risk over the medium term despite low nominal debt.
Revenue Volatility And Recent DeclineVolatile top-line and a 2025 year-on-year decline weaken predictability for margins and cash flow. Revenue instability complicates cost absorption and planning, and when paired with gross-margin compression it risks making margin recovery and sustainable profitability harder to achieve.
Zhong Ji Longevity Science Group Limited News
0767 FAQ
What was Zhong Ji Longevity Science Group Limited’s price range in the past 12 months?
Zhong Ji Longevity Science Group Limited lowest stock price was HK$0.32 and its highest was HK$0.72 in the past 12 months.
What is Zhong Ji Longevity Science Group Limited’s market cap?
Zhong Ji Longevity Science Group Limited’s market cap is HK$267.39M.
When is Zhong Ji Longevity Science Group Limited’s upcoming earnings report date?
Zhong Ji Longevity Science Group Limited’s upcoming earnings report date is Aug 31, 2026 which is in 80 days.
How were Zhong Ji Longevity Science Group Limited’s earnings last quarter?
Zhong Ji Longevity Science Group Limited released its earnings results on Mar 26, 2026. The company reported -HK$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.007.
Is Zhong Ji Longevity Science Group Limited overvalued?
According to Wall Street analysts Zhong Ji Longevity Science Group Limited’s price is currently Overvalued.
Does Zhong Ji Longevity Science Group Limited pay dividends?
Zhong Ji Longevity Science Group Limited does not currently pay dividends.
What is Zhong Ji Longevity Science Group Limited’s EPS estimate?
Zhong Ji Longevity Science Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zhong Ji Longevity Science Group Limited have?
Zhong Ji Longevity Science Group Limited has 636,654,300 shares outstanding.
What happened to Zhong Ji Longevity Science Group Limited’s price movement after its last earnings report?
Zhong Ji Longevity Science Group Limited reported an EPS of -HK$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1%.
Which hedge fund is a major shareholder of Zhong Ji Longevity Science Group Limited?
Currently, no hedge funds are holding shares in HK:0767
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Zhong Ji Longevity Science Group Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
120.33%
12-Months-Change
Fundamentals
Return on Equity
-4.17%
Trailing 12-Months
Asset Growth
-4.89%
Trailing 12-Months
Company Description
Zhong Ji Longevity Science Group Limited
Zhong Ji Longevity Science Group Limited operates as an investment holding entity, engaging in a broad spectrum of commercial endeavors. Its operations include providing money lending solutions across Hong Kong and Mainland China. The company's healthcare division delivers diagnostic advisory services, medical examination and testing, and the supply of health-related supplements. Furthermore, Zhong Ji Longevity is involved in holding equity stakes, investing in both short and long-term financial instruments, offering financial and investment advisory, and property acquisition. It also extends health advisory services and deals in medical commodities. Founded in 1994, the company was formerly known as Asia Pacific Silk Road Investment Company Limited before rebranding to its current name in March 2021. Its main office is situated in Causeway Bay, Hong Kong.
Technical Analysis
Zhaobangji Properties Holdings Limited
―
China Properties Investment Holdings Limited
―
Hao Wen Holdings Ltd.
―
Ziyuanyuan Holdings Group Ltd.
―
Baiying Holdings Group Ltd.
―